PHGE (BiomX Inc.) Stock Analysis - Analyst Ratings

BiomX Inc. (PHGE) is a publicly traded Healthcare sector company. As of May 21, 2026, PHGE trades at $0.63 with a market cap of $4.66M and a P/E ratio of 0.03. PHGE moved +56.95% today. Year to date, PHGE is -73.59%; over the trailing twelve months it is -94.25%. Its 52-week range spans $0.36 to $22.06. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces PHGE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate PHGE?

1 analysts cover PHGE: 0 strong buy, 0 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $0.00.

PHGE Key Metrics

Key financial metrics for PHGE
MetricValue
Price$0.63
Market Cap$4.66M
P/E Ratio0.03
EPS$22.19
Dividend Yield0.00%
52-Week High$22.06
52-Week Low$0.36
Volume3.40M
Avg Volume0
Revenue (TTM)$0
Net Income$-36.20M
Gross Margin0.00%

PHGE Analyst Consensus

1 analysts cover PHGE: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.

Latest PHGE News

Recent PHGE Insider Trades

  • Yeganeh Reuven sold 530.00K (~$2.65M) on Mar 17, 2026.
  • Yeganeh Reuven sold 450.00K (~$2.25M) on Mar 16, 2026.
  • Yeganeh Reuven sold 370.00K (~$1.85M) on Mar 13, 2026.

Common questions about PHGE

What do analysts rate PHGE?
1 analysts cover PHGE: 0 strong buy, 0 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $0.00.
Does Rallies show PHGE price targets?
Yes. Rallies tracks PHGE analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is PHGE research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PHGE. It does not provide personalized investment advice.
PHGE

PHGE